Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
A phase 2 trial of Bladder EpiCheck urine methylation test in Non-muscle-invasive bladder cancer, run by White River Junction Veterans Affairs Medical Center, now recruiting.
Overview
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance is a phase 2 interventional study registered as NCT05796375 by White River Junction Veterans Affairs Medical Center, with 240 participants planned, started 2023-11-17 and due to reach its primary completion in 2028-11-30. Interventions recorded: Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test. Conditions recorded: Non-muscle-invasive Bladder Cancer.
Linked to the technology Bladder EpiCheck urine methylation test because the registry names it ("epicheck") among its interventions and Non-muscle-invasive bladder cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialIntravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialLEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialSafety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialA Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialA Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialSafety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With High-grade, BCG Unresponsive, Non-muscle Invasive Bladder Cancer (NMIBC)
Shares Non-muscle-invasive bladder cancer and the tag pipeline.
- TrialEfficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Shares Non-muscle-invasive bladder cancer and the tag pipeline.